NeoGenomics and Goldman Sachs

Selected Headlines

Date Headline (link) Source Relevant Snippet
9/29/2021 NeoGenomics (NASDAQ:NEO) Trading Down 3.9% - Ticker Report Ticker Report NeoGenomics, Inc. (NASDAQ:NEO)‚Aos share price fell 3.9% on Monday . The company traded as low as $44.83 and last traded at $45.03. 2,790 shares were traded during trading, a decline of 100% from the average session volume of 833,041 shares. The stock had previously closed at $46.86.A number of research firms have recently weighed in on NEO. The Goldman Sachs Group began coverage on shares of NeoGenomics in ...
9/29/2021 NeoGenomics (NASDAQ:NEO) Trading Up 5.3% American Banking News Shares of NeoGenomics, Inc. (NASDAQ:NEO) were up 5.3% during mid-day trading on Wednesday . The company traded as high as $48.89 and last traded at $48.70. Approximately 13,088 shares traded hands during trading, a ... of NeoGenomics in a report on Monday, August 9th. The Goldman Sachs Group assumed coverage on NeoGenomics in a research report on Thursday, June 3rd. They set a ‚Aubuy‚Au rating and a $55.00 target ...
9/29/2021 NeoGenomics (NASDAQ:NEO) Trading Up 5.3% Shares of NeoGenomics, Inc. (NASDAQ:NEO) were up 5.3% during mid-day trading on Wednesday . The company traded as high as $48.89 and last traded at $48.70. Approximately 13,088 shares traded hands during trading, a ... of NeoGenomics in a report on Monday, August 9th. The Goldman Sachs Group assumed coverage on NeoGenomics in a research report on Thursday, June 3rd. They set a ‚Aubuy‚Au rating and a $55.00 target ...
9/27/2021 NeoGenomics (NASDAQ:NEO) Trading Down 3.9% American Banking News NeoGenomics, Inc. (NASDAQ:NEO) traded down 3.9% during mid-day trading on Monday . The company traded as low as $44.83 and last traded at $45.03. 2,790 shares were traded during trading, a decline of 100% from the average session volume of 833,041 shares. The stock had previously closed at $46.86.A number of brokerages recently commented on NEO. The Goldman Sachs Group began coverage on shares of NeoGenomics in a ...
9/25/2021 NeoGenomics (NASDAQ:NEO) Trading 4.7% Higher - Stock Observer NeoGenomics, Inc. (NASDAQ:NEO) traded up 4.7% on Thursday . The stock traded as high as $53.40 and last traded at $52.46. 13,525 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 827,121 shares. The stock had previously closed at $50.12.Several equities analysts have recently weighed in on the company. The Goldman Sachs Group assumed coverage on NeoGenomics in a research report ...
9/24/2021 Stock Traders Purchase Large Volume of Call Options on NeoGenomics (NASDAQ:NEO) American Banking News NeoGenomics, Inc. (NASDAQ:NEO) saw some unusual options trading on Thursday. Stock traders acquired 3,480 call options on the company. This is an increase of 1,008% daily volume of 314 call options.A number of ... in a research note on Thursday, August 26th. Finally, The Goldman Sachs Group began coverage on shares of NeoGenomics in a research note on Thursday, June 3rd. They issued a ‚Aubuy‚Au rating and a ...
9/23/2021 NeoGenomics (NASDAQ:NEO) Trading Up 4.7% American Banking News NeoGenomics, Inc. (NASDAQ:NEO)‚Aos stock price was up 4.7% on Thursday . The company traded as high as $53.40 and last traded at $52.46. Approximately 13,525 shares traded hands during mid-day trading, a decline ... stock in a research report on Monday, August 9th. The Goldman Sachs Group started coverage on NeoGenomics in a research report on Thursday, June 3rd. They issued a ‚Aubuy‚Au rating and a $55.00 price ...
9/20/2021 NeoGenomics, Inc. (NASDAQ:NEO) Receives $52.81 Consensus Target Price from Brokerages NeoGenomics, Inc. (NASDAQ:NEO) has earned a consensus rating of ‚AuBuy‚Au from the eleven research firms that are currently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold ... NeoGenomics in a research note on Monday, August 9th. The Goldman Sachs Group assumed coverage on NeoGenomics in a research note on Thursday, June 3rd. They set a ‚Aubuy‚Au rating and a $55.00 price ...
9/13/2021 NeoGenomics, Inc. (NASDAQ:NEO) Expected to Post Quarterly Sales of $126.27 Million Wall Street brokerages expect NeoGenomics, Inc. (NASDAQ:NEO) to post $126.27 million in sales for the current fiscal quarter, according to Zacks . Three analysts have provided estimates for NeoGenomics‚Ao earnings. The highest sales estimate ... the subject of a number of recent analyst reports. The Goldman Sachs Group initiated coverage on shares of NeoGenomics in a research note on Thursday, June 3rd. They set a ‚Aubuy‚Au rating and a ...
9/12/2021 NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of ‚ÄúBuy‚Äù by Brokerages - Stock Observer NeoGenomics, Inc. (NASDAQ:NEO) has received an average rating of ‚AuBuy‚Au from the eleven research firms that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold ... the company in a report on Monday, August 9th. The Goldman Sachs Group began coverage on shares of NeoGenomics in a report on Thursday, June 3rd. They set a ‚Aubuy‚Au rating and a $55.00 ...
9/6/2021 Analysts Anticipate NeoGenomics, Inc. (NASDAQ:NEO) Will Post Earnings of -$0.07 Per Share Wall Street analysts forecast that NeoGenomics, Inc. (NASDAQ:NEO) will report earnings per share of ($0.07) for the current quarter, according to Zacks Investment Research . Three analysts have made estimates for NeoGenomics‚Ao earnings, with ... equities research analysts have weighed in on NEO shares. The Goldman Sachs Group started coverage on shares of NeoGenomics in a research note on Thursday, June 3rd. They issued a ‚Aubuy‚Au rating and a ...
9/4/2021 NeoGenomics (NASDAQ:NEO) Updates FY 2021 Earnings Guidance Mayfield Recorder NeoGenomics (NASDAQ:NEO) updated its FY 2021 earnings guidance on Friday. The company provided earnings per share guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-0.210. The company issued revenue guidance of $490 million-$510 million, compared to the consensus revenue estimate of $500.22 million. A number of analysts have commented on the stock. The Goldman Sachs Group assumed coverage ...
9/3/2021 NeoGenomics (NASDAQ:NEO) Releases FY 2021 Earnings Guidance NeoGenomics (NASDAQ:NEO) updated its FY 2021 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus estimate of $-0.210. The ... NeoGenomics in a research report on Monday, August 9th. The Goldman Sachs Group began coverage on NeoGenomics in a research report on Thursday, June 3rd. They issued a buy rating and a $55.00 price objective ...
8/30/2021 NeoGenomics (NASDAQ:NEO) Updates FY 2021 Earnings Guidance NeoGenomics (NASDAQ:NEO) issued an update on its FY 2021 earnings guidance on Friday morning. The company provided earnings per share guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus earnings ... NeoGenomics in a research report on Monday, August 9th. The Goldman Sachs Group assumed coverage on shares of NeoGenomics in a research report on Thursday, June 3rd. They issued a buy rating and a $55.00 ...
8/30/2021 NeoGenomics (NASDAQ:NEO) Price Target Raised to $50.00 NeoGenomics (NASDAQ:NEO) had its target price hoisted by Benchmark from $46.00 to $50.00 in a research note published on Thursday morning, The Fly reports. The firm currently has a buy rating on the medical ... company in a research note on Monday, August 9th. The Goldman Sachs Group assumed coverage on shares of NeoGenomics in a research note on Thursday, June 3rd. They issued a buy rating and a $55.00 ...
8/29/2021 NeoGenomics (NASDAQ:NEO) Issues FY 2021 Earnings Guidance NeoGenomics (NASDAQ:NEO) updated its FY 2021 earnings guidance on Friday. The company provided EPS guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus EPS estimate of $-0.210. The company issued ... the company in a report on Monday, August 9th. The Goldman Sachs Group began coverage on shares of NeoGenomics in a report on Thursday, June 3rd. They set a buy rating and a $55.00 price ...
8/29/2021 Benchmark Boosts NeoGenomics (NASDAQ:NEO) Price Target to $50.00 NeoGenomics (NASDAQ:NEO) had its price target boosted by Benchmark from $46.00 to $50.00 in a report released on Thursday, The Fly reports. The brokerage currently has a buy rating on the medical research company ... NeoGenomics in a research note on Monday, August 9th. The Goldman Sachs Group started coverage on shares of NeoGenomics in a research note on Thursday, June 3rd. They set a buy rating and a $55.00 ...
8/26/2021 NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Recommendation of ‚ÄúBuy‚Äù from Analysts - Transcript Daily NeoGenomics, Inc. (NASDAQ:NEO) has received a consensus rating of ‚AuBuy‚Au from the twelve brokerages that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating ... in a research report on Tuesday, August 17th. Finally, The Goldman Sachs Group initiated coverage on NeoGenomics in a research report on Thursday, June 3rd. They set a ‚Aubuy‚Au rating and a $55.00 target ...
8/26/2021 Benchmark Boosts NeoGenomics (NASDAQ:NEO) Price Target to $50.00 - Watch List News NeoGenomics (NASDAQ:NEO) had its price objective upped by equities researchers at Benchmark from $46.00 to $50.00 in a note issued to investors on Thursday, The Fly reports. The firm currently has a ‚Aubuy‚Au ... analysts have also recently weighed in on the stock. The Goldman Sachs Group assumed coverage on shares of NeoGenomics in a research report on Thursday, June 3rd. They set a ‚Aubuy‚Au rating and a ...
8/25/2021 Analysts Set NeoGenomics, Inc. (NASDAQ:NEO) PT at $51.83 - Stock Observer NeoGenomics, Inc. (NASDAQ:NEO) has been assigned a consensus rating of ‚AuBuy‚Au from the twelve ratings firms that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a ... the company in a report on Monday, August 9th. The Goldman Sachs Group assumed coverage on NeoGenomics in a research report on Thursday, June 3rd. They issued a ‚Aubuy‚Au rating and a $55.00 price ...
8/23/2021 Brokerages Anticipate NeoGenomics, Inc. (NASDAQ:NEO) to Post -$0.07 Earnings Per Share Daily Political Brokerages Anticipate NeoGenomics, Inc. (NASDAQ:NEO) to Post -$0.07 Earnings Per Share Posted by Tyrone Williams on Aug 22nd, 2021 Share on StocktwitsWall Street analysts expect NeoGenomics, Inc. (NASDAQ:NEO) to report earnings per ... Several equities analysts recently weighed in on NEO shares. The Goldman Sachs Group initiated coverage on shares of NeoGenomics in a research report on Thursday, June 3rd. They set a ‚Aubuy‚Au rating and a ...
8/23/2021 NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Recommendation of ‚ÄúBuy‚Äù from Analysts Shares of NeoGenomics, Inc. (NASDAQ:NEO) have received an average rating of ‚AuBuy‚Au from the twelve ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the ... company in a research report on Monday, August 9th. The Goldman Sachs Group began coverage on NeoGenomics in a research report on Thursday, June 3rd. They set a ‚Aubuy‚Au rating and a $55.00 price ...
8/22/2021 NeoGenomics (NASDAQ:NEO) Updates FY 2021 Earnings Guidance NeoGenomics (NASDAQ:NEO) issued an update on its FY 2021 earnings guidance on Friday morning. The company provided earnings per share guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus earnings ... rating in a research note on Tuesday, August 17th. The Goldman Sachs Group assumed coverage on NeoGenomics in a research note on Thursday, June 3rd. They set a buy rating and a $55.00 price objective ...
8/21/2021 NeoGenomics (NASDAQ:NEO) Updates FY 2021 Earnings Guidance NeoGenomics (NASDAQ:NEO) issued an update on its FY 2021 earnings guidance on Friday morning. The company provided earnings per share guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus earnings ... has been the subject of several recent research reports. The Goldman Sachs Group started coverage on NeoGenomics in a report on Thursday, June 3rd. They set a buy rating and a $55.00 price target for ...
8/21/2021 NeoGenomics (NASDAQ:NEO) Raised to ‚ÄúHold‚Äù at Zacks Investment Research Zacks Investment Research upgraded shares of NeoGenomics (NASDAQ:NEO) from a sell rating to a hold rating in a research report report published on Tuesday morning, Zacks.com reports. According to Zacks, ‚AuNeoGenomics, Inc. is a ... in a research report on Monday, August 9th. Finally, The Goldman Sachs Group started coverage on NeoGenomics in a research report on Thursday, June 3rd. They issued a buy rating and a $55.00 price objective ...